CollPlant Biotechnologies annual current ratio
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Current Ratio Growth & History (CLGN)
CollPlant Biotechnologies's current ratio was 2.53 for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.53 | −1.91 | −43.10% |
| 2024 | 2024-12-31 | 4.44 | −4.18 | −48.52% |
| 2023 | 2023-12-31 | 8.62 | −1.58 | −15.46% |
| 2022 | 2022-12-31 | 10.20 | −4.76 | −31.84% |
| 2021 | 2021-12-31 | 14.96 | 13.28 | +792.91% |
| 2020 | 2020-12-31 | 1.68 | 0.22 | +14.91% |
| 2019 | 2019-12-31 | 1.46 | −1.75 | −54.61% |
| 2018 | 2018-12-31 | 3.21 | −1.34 | −29.50% |
| 2017 | 2017-12-31 | 4.56 | — | — |
CollPlant Biotechnologies quarterly current ratio
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 2.27 | −2.21 | −49.36% |
| Q4 2025 | 2025-12-31 | 2.53 | −1.91 | −43.10% |
| Q3 2025 | 2025-09-30 | 3.66 | — | — |
| Q2 2025 | 2025-06-30 | 4.60 | −1.67 | −26.62% |
| Q1 2025 | 2025-03-31 | 4.48 | — | — |
| Q4 2024 | 2024-12-31 | 4.44 | −4.18 | −48.52% |
| Q2 2024 | 2024-06-30 | 6.27 | −6.26 | −49.93% |
| Q4 2023 | 2023-12-31 | 8.62 | −1.58 | −15.46% |
| Q2 2023 | 2023-06-30 | 12.53 | −3.68 | −22.70% |
| Q4 2022 | 2022-12-31 | 10.20 | −4.76 | −31.84% |
| Q2 2022 | 2022-06-30 | 16.21 | −0.76 | −4.47% |
| Q4 2021 | 2021-12-31 | 14.96 | 13.28 | +792.91% |
| Q2 2021 | 2021-06-30 | 16.97 | 14.45 | +573.15% |
| Q4 2020 | 2020-12-31 | 1.68 | 0.22 | +14.91% |
| Q2 2020 | 2020-06-30 | 2.52 | 1.42 | +129.96% |
| Q4 2019 | 2019-12-31 | 1.46 | −1.75 | −54.61% |
| Q2 2019 | 2019-06-30 | 1.10 | −2.85 | −72.24% |
| Q4 2018 | 2018-12-31 | 3.21 | −1.34 | −29.50% |
| Q2 2018 | 2018-06-30 | 3.95 | — | — |
| Q4 2017 | 2017-12-31 | 4.56 | — | — |
CollPlant Biotechnologies current ratio trends
Over the last five fiscal years, CollPlant Biotechnologies's current ratio increased from 1.68 to 2.53, a change of 0.85. The latest reported quarter, Q1 2026, shows 2.27.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies source filings ↗